Picture of Avecho Biotechnology logo

AVE Avecho Biotechnology News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: Avecho Biotechnology Signs Licensing And Development Agreement With Arthur Group Llc

May 22 (Reuters) - Avecho Biotechnology Ltd  AVE.AX :
    * SIGNED A LICENSING AND DEVELOPMENT AGREEMENT WITH ARTHUR
GROUP
LLC
    * AGREEMENT INCLUDES RIGHTS TO FIVE SEPARATE ONCOLOGY
PRODUCTS,
REPRESENTING COMBINED US MARKET OF US$2.92 BILLION
    * AGREEMENT FOR FOR DEVELOPMENT OF A SERIES OF LEADING
CANCER
DRUGS
    * UNDER DEAL, AVECHO WILL RECEIVE 30% OF REVENUE FROM
LICENSING
AND 30% OF NET PROFIT FROM COMMERCIALISATION OF PRODUCTS

Source text for Eikon:  ID:nASX8zntWH 
Further company coverage:  AVE.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Avecho Biotechnology

See all news